Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)

@inproceedings{Mont2014CatheterAV,
  title={Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)},
  author={Llu{\'i}s Mont and Felipe Bisbal and Antonio Hern{\'a}ndez-Madrid and Nicasio P{\'e}rez-Castellano and Xavier Vi{\~n}olas and Angel Arenal and Fernando Arribas and Ignacio Fern{\'a}ndez-Lozano and Andr{\'e}s Ignacio Bodegas and A. Mu{\~n}oz Cobos and Roberto Mat{\'i}a and Juli{\'a}n P{\'e}rez-Villacast{\'i}n and Jos{\'e} Manuel Guerra and Pablo Justo Avila and Mar{\'i}a L{\'o}pez-Gil and Victor Castro and Jos{\'e} Ignacio Arana and Josep Brugada},
  booktitle={European heart journal},
  year={2014}
}
BACKGROUND Catheter ablation (CA) is a highly effective therapy for the treatment of paroxysmal atrial fibrillation (AF) when compared with antiarrhythmic drug therapy (ADT). No randomized studies have compared the two strategies in persistent AF. The present randomized trial aimed to compare the effectiveness of CA vs. ADT in treating persistent AF. METHODS AND RESULTS Patients with persistent AF were randomly assigned to CA or ADT (excluding patients with long-standing persistent AF… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 8 times over the past 90 days. VIEW TWEETS
70 Citations
24 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 70 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Similar Papers

Loading similar papers…